Back
AngioDynamics 10K Form
Sell
35
ANGO
AngioDynamics
Last Price:
6.08
Seasonality Move:
4.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-09 | 10Q | ANGO/AngioDynamics Quarterly |
2024-01-08 | 10Q | ANGO/AngioDynamics Quarterly |
2023-10-05 | 10Q | ANGO/AngioDynamics Quarterly |
2023-03-31 | 10Q | ANGO/AngioDynamics Quarterly |
2023-01-06 | 10Q | ANGO/AngioDynamics Quarterly |
2022-10-11 | 10Q | ANGO/AngioDynamics Quarterly |
Receive ANGO News And Ratings
See the #1 stock for the next 7 days that we like better than ANGO
ANGO Financial Statistics
Sales & Book Value
Annual Sales: | $338.75M |
---|---|
Cash Flow: | $-16.38M |
Price / Cash Flow: | 0 |
Annual Sales: | $5.41 |
Price / Book: | 1.06 |
Profitability
EPS (TTM): | -4.78000 |
---|---|
Net Income (TTM): | $-192.37M |
Gross Margin: | $174.25M |
Return on Equity: | -52.74% |
Return on Assets: | -40.18% |
AngioDynamics Earnings Forecast
Key AngioDynamics Financial Ratios
- The Gross Profit Margin over the past 23 years for ANGO is 51.44%.
- The Selling, General & Administrative Expenses for ANGO have been equal to 42.58% of Gross Profit Margin.
- The Research & Development expenses have been 8.82% of Revenue.
- The Interest Expense is -5.15% of Operating Income.
- The Net Earning history of ANGO is -15.48% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 14 years.
AngioDynamics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | ANGO |
CUSIP: | 03475V |
Website: | angiodynamics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 2.29 |
Quick Ratio: | 1.49 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
ANGO Technical Analysis vs Fundamental Analysis
Sell
35
AngioDynamics (ANGO)
is a Sell
Is AngioDynamics a Buy or a Sell?
-
AngioDynamics stock is rated a Sell
The current AngioDynamics [ANGO] share price is $5.79. The Score for ANGO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.